Suggestions
Yangbing Zhao
M.D&Ph.D
Yangbing Zhao is a prominent figure in the field of cancer immunotherapy, with a major interest in T cell based gene and adoptive cell therapies. He has held key positions in various prestigious organizations.
Currently, Yangbing Zhao serves as the President & CSO at UTC Therapeutics Inc. He previously held the role of Director at the T Cell Engineering Lab (TCEL) and Adjunct Associate Professor at the University of Pennsylvania.
Prior to his current role, he was a Research Fellow at the Surgery Branch under NCI/NIH. Additionally, Yangbing Zhao has worked as a Research Associate at Duke University Medical Center and has experience as a Post-Doc and Visiting Scientist at The Weizmann Institute of Science.
Highlights
Sep 1 · aacr.org
Advances in Immunotherapy: Fine-tuning CAR T Cells
Get intro to Yangbing
Add to my network
Location
Shanghai, China
People also viewed
Ben Black
Managing Partner, Fortinbras Enterprises
Ryun Hobbs
Associate Director, Analytics at iProspect
Alejandro Monteys
Instructor at University of Pennsylvania
Mutual Connections
See who you know in common with Yangbing
Clay can make mistakes, so please verify responses. Data is from public sources. Trademarks are property of their respective owners.
People also viewed
Ben Black
Managing Partner, Fortinbras Enterprises
Ryun Hobbs
Associate Director, Analytics at iProspect
Alejandro Monteys
Instructor at University of Pennsylvania
Mutual Connections
See who you know in common with Yangbing